What is Saxenda?

What is Saxenda?
Saxenda is a widely used treatment for weight management. But what exactly is it, and when is it used? In this blog post, we explain what Saxenda is, how it works as part of a medical treatment plan, and why it might be a part of your weight loss journey with the Goodweigh program.
What was Saxenda developed for?
Saxenda was developed specifically for the medical treatment of overweight and obesity in adults, not for the treatment of type 2 diabetes. This distinction is important: while similar medications, such as Ozempic, are primarily approved for lowering blood sugar, Saxenda is registered exclusively for weight management. According to a review published in the JAMA journal, medication is now considered a standard part of obesity treatment when lifestyle changes do not yield sufficient results. Saxenda fits perfectly into this clinical practice: it is a tool for people who struggle to lose weight despite their best efforts.
Which drug class does Saxenda belong to?
Saxenda contains the active ingredient liraglutide and belongs to the class of GLP-1 receptor agonists. GLP-1 is a hormone that the body produces naturally after a meal. It stimulates insulin release, inhibits the action of glucagon (a hormone that raises blood sugar), and signals satiety via the hypothalamus. Liraglutide mimics this hormone: it has 97 percent sequence homology with endogenous GLP-1 and a half-life of approximately 13 hours, which is why it must be administered as a daily subcutaneous injection. More information on the mechanism of action of Saxenda can be found in a separate blog post. According to a review published in the JAMA journal, GLP-1 receptor agonists are currently one of the most well-researched classes of weight management medications available.
Who is Saxenda for?
Saxenda is intended for adults with a BMI of 30 or higher, or for individuals with a BMI of 27 or higher who have a weight-related condition, such as high blood pressure, sleep apnea, or prediabetes. The indication is always determined by a physician: a doctor will assess whether Saxenda is suitable for your specific situation. A randomized controlled trial foundthat participants who received 3 mg of liraglutide lost significantly more weight on average than the control group, especially when the medication was used in conjunction with a calorie-restricted diet and increased physical activity. Want to know if you are eligible? The criteria for GLP-1 medication are explained comprehensively on our knowledge base page.
What is the difference between Saxenda and conventional weight loss methods?
Diet and exercise are the foundation of every healthy weight loss process, but for some people, they are not enough. Overweight often has a complex biological background: it is influenced by disrupted hunger and satiety regulation mechanisms, a slowed resting metabolism, or hormonal factors. Saxenda acts directly on these mechanisms. By affecting the hunger and satiety centers in the hypothalamus, liraglutide helps reduce appetite and slow gastric emptying, which keeps you feeling full longer after a meal. This is a physiologically different mechanism than relying solely on willpower or managing your diet by controlling portion sizes. Extensive A review in The Lancet concludedthat medical support for severe obesity provides proven added value compared to lifestyle changes alone. Saxenda is therefore not a quick fix, but a medical tool that works through proven biological pathways.
Does Saxenda replace lifestyle changes?
No. This is a crucial point. Saxenda supports behavioral change, but it does not replace it. The medication is always intended to complement a healthier diet and increased physical activity, not to replace them. This is also how Goodweigh uses it: medication as a tool within a broader process, with coaching and progress tracking at its core. If Saxenda is used without paying attention to lifestyle, the results will be more modest, and the risk of a setback after treatment ends is higher.
What can you expect from a Saxenda treatment program at Goodweigh?
At Goodweigh, every treatment program begins with an online questionnaire, followed by a medical assessment by a doctor. The doctor will evaluate whether Saxenda is suitable for you based on your health history, BMI, and any potential contraindications, such as a history of pancreatitis or pregnancy. Once Saxenda is prescribed, it is delivered discreetly to your home. The dosage is increased gradually to minimize common initial side effects, such as nausea or diarrhea. During treatment, you will receive guidance, and your progress and reaction to the medication will be monitored. More information about the Goodweigh program can be found on our program page. A randomized controlled trial foundthat guidance and monitoring significantly increase the effectiveness of liraglutide. On the Saxenda product page you will find all the practical information about the medication itself, including instructions for use and how long a Saxenda pen lasts.
How does Saxenda differ from other medications, such as Ozempic or Wegovy?
The main practical differences relate to the active ingredient, dosing frequency, and registered indication. Saxenda contains liraglutide and is injected daily. Ozempic and Wegovy contain semaglutide and are administered once a week. A direct comparative study revealedthat weekly semaglutide led to greater average weight loss than daily liraglutide. A study published in The Lancet showedthat at higher doses, semaglutide was more effective than liraglutide in achieving weight loss of over five percent. This does not mean that Saxenda is less suitable: the choice depends on your health status, personal preferences, and tolerance. A comprehensive overview Differences between Ozempic and Saxenda can be found in a separate blog post.
Is Saxenda right for you?
Saxenda is one of the proven options in the Goodweigh program for individuals struggling with weight who are seeking medical guidance. Whether it is suitable for your situation depends on your BMI, health history, and personal goals. Complete our initial questionnaire so that we, together with a doctor, can evaluate which treatment is best for you.
Viitteet
- Pi-Sunyer, X. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/26132939/
- Elmaleh-Sachs, A. (2023). Management of obesity in adults: a review. JAMA. https://pubmed.ncbi.nlm.nih.gov/38015216/
- Rubino, D. M. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight. JAMA. https://pubmed.ncbi.nlm.nih.gov/35015037/
- O'Neil, P. M. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss. Lancet. https://pubmed.ncbi.nlm.nih.gov/30122305/
- Bray, G. A. (2016). Management of obesity. Lancet. https://pubmed.ncbi.nlm.nih.gov/26868660/
- Pharmacotherapeutic Compass. Liraglutide. https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/l/liraglutide



